0001624658-22-000001.txt : 20220517 0001624658-22-000001.hdr.sgml : 20220517 20220517154417 ACCESSION NUMBER: 0001624658-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220517 DATE AS OF CHANGE: 20220517 EFFECTIVENESS DATE: 20220517 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Allena Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001624658 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 452729920 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-445953 FILM NUMBER: 22934222 BUSINESS ADDRESS: STREET 1: ONE NEWTON EXECUTIVE PARK STREET 2: SUITE 202 CITY: NEWTON STATE: MA ZIP: 02462 BUSINESS PHONE: 617-467-4577 MAIL ADDRESS: STREET 1: ONE NEWTON EXECUTIVE PARK STREET 2: SUITE 202 CITY: NEWTON STATE: MA ZIP: 02462 D 1 primary_doc.xml X0708 D LIVE 0001624658 Allena Pharmaceuticals, Inc. ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA MASSACHUSETTS 02462 617-467-4577 DELAWARE None None Corporation true Louis Brenner, M.D. One Newton Executive Park Suite 202 Newton MA MASSACHUSETTS 02462 Executive Officer Director Richard D. Katz, M.D. One Newton Executive Park Suite 202 Newton MA MASSACHUSETTS 02462 Executive Officer Alexey Margolin One Newton Executive Park Suite 202 Newton MA MASSACHUSETTS 02462 Director Gino Santini One Newton Executive Park Suite 202 Newton MA MASSACHUSETTS 02462 Director Allene Diaz One Newton Executive Park Suite 202 Newton MA MASSACHUSETTS 02462 Director Ann C. Miller One Newton Executive Park Suite 202 Newton MA MASSACHUSETTS 02462 Director Mark Fitzpatrick One Newton Executive Park Suite 202 Newton MA MASSACHUSETTS 02462 Director Pharmaceuticals Decline to Disclose 06b false 2022-05-04 false true false 0 H.C. Wainwright & Co., LLC 375 None None 430 PARK AVENUE 4TH FLOOR NEW YORK NY NEW YORK 10022 All States false 4052406 4052406 0 Includes warrants to buy up to 22,438,575 shares of common stock at an exercise price of $0.1694/share issued to the investor and up to 1,256,561 shares of common stock at an exercise price of $0.20/share issued to H.C.Wainwright&Co.LLC and its affiliates false 5 314771 0 H.C. Wainwright & Co., LLC received the above sales commission and the warrants in connection with the private placement and a concurrent registered direct offering by the Issuer, which is not reported on this Form D. 0 false Allena Pharmaceuticals, Inc. Louis Brenner, M.D. Louis Brenner, M.D. President and Chief Executive Officer 2022-05-17